281 related articles for article (PubMed ID: 32173168)
1. Push-Dose Vasopressin for Hypotension in Septic Shock.
Nowadly CD; Catlin JR; Fontenette RW
J Emerg Med; 2020 Feb; 58(2):313-316. PubMed ID: 32173168
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.
Bissell BD; Magee C; Moran P; Bastin MLT; Flannery AH
J Intensive Care Med; 2019 Sep; 34(9):761-765. PubMed ID: 28750598
[TBL] [Abstract][Full Text] [Related]
3. Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock.
Sacha GL; Lam SW; Duggal A; Torbic H; Reddy AJ; Bauer SR
Pharmacotherapy; 2018 Mar; 38(3):319-326. PubMed ID: 29328496
[TBL] [Abstract][Full Text] [Related]
4. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
[TBL] [Abstract][Full Text] [Related]
5. The incidence of cardiovascular instability in patients receiving various vasopressor strategies for peri-intubation hypotension.
Schmitt CJ; Mattson AE; Brown CS; Mara KC; Cabrera D; Sandefur BJ; Wieruszewski ED
Am J Emerg Med; 2023 Mar; 65():104-108. PubMed ID: 36603354
[TBL] [Abstract][Full Text] [Related]
6. Low-dose vasopressin in the treatment of vasodilatory septic shock.
Malay MB; Ashton RC; Landry DW; Townsend RN
J Trauma; 1999 Oct; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
[TBL] [Abstract][Full Text] [Related]
7. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
Morelli A; Ertmer C; Rehberg S; Lange M; Orecchioni A; Cecchini V; Bachetoni A; D'Alessandro M; Van Aken H; Pietropaoli P; Westphal M
Crit Care; 2009; 13(4):R130. PubMed ID: 19664253
[TBL] [Abstract][Full Text] [Related]
8. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.
Daley MJ; Lat I; Mieure KD; Jennings HR; Hall JB; Kress JP
Ann Pharmacother; 2013 Mar; 47(3):301-10. PubMed ID: 23447481
[TBL] [Abstract][Full Text] [Related]
9. Vasopressor Discontinuation Order in Septic Shock With Reduced Left Ventricular Function.
Taylor A; Jones T; Forehand CC; Smith SE; Dykes H; Newsome AS
J Pharm Pract; 2022 Dec; 35(6):879-885. PubMed ID: 33977793
[TBL] [Abstract][Full Text] [Related]
10. Effects of the discontinuation sequence of norepinephrine and vasopressin on hypotension incidence in patients with septic shock: A meta-analysis.
Duclos G; Baumstarck K; Dünser M; Zieleskiewicz L; Leone M
Heart Lung; 2019; 48(6):560-565. PubMed ID: 31126701
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin versus norepinephrine infusion in patients with septic shock.
Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
[TBL] [Abstract][Full Text] [Related]
12. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock.
Hammond DA; McCain K; Painter JT; Clem OA; Cullen J; Brotherton AL; Chopra D; Meena N
J Intensive Care Med; 2019 Oct; 34(10):805-810. PubMed ID: 28618919
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Bolus-dose Phenylephrine for Peri-intubation Hypotension.
Panchal AR; Satyanarayan A; Bahadir JD; Hays D; Mosier J
J Emerg Med; 2015 Oct; 49(4):488-94. PubMed ID: 26104846
[TBL] [Abstract][Full Text] [Related]
14. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
Gordon AC; Mason AJ; Thirunavukkarasu N; Perkins GD; Cecconi M; Cepkova M; Pogson DG; Aya HD; Anjum A; Frazier GJ; Santhakumaran S; Ashby D; Brett SJ;
JAMA; 2016 Aug; 316(5):509-18. PubMed ID: 27483065
[TBL] [Abstract][Full Text] [Related]
15. Does body weight impact the efficacy of vasopressin therapy in the management of septic shock?
Miller JT; Welage LS; Kraft MD; Alaniz C
J Crit Care; 2012 Jun; 27(3):289-93. PubMed ID: 21855282
[TBL] [Abstract][Full Text] [Related]
16. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock.
van Haren FM; Rozendaal FW; van der Hoeven JG
Chest; 2003 Dec; 124(6):2256-60. PubMed ID: 14665508
[TBL] [Abstract][Full Text] [Related]
17. Selepressin, a novel selective vasopressin V
Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L
Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037
[TBL] [Abstract][Full Text] [Related]
18. Effects of Norepinephrine and Vasopressin Discontinuation Order in the Recovery Phase of Septic Shock: A Systematic Review and Individual Patient Data Meta-Analysis.
Hammond DA; Sacha GL; Bissell BD; Musallam N; Altshuler D; Flannery AH; Lam SW; Bauer SR
Pharmacotherapy; 2019 May; 39(5):544-552. PubMed ID: 30893494
[TBL] [Abstract][Full Text] [Related]
19. Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial.
Permpikul C; Tongyoo S; Viarasilpa T; Trainarongsakul T; Chakorn T; Udompanturak S
Am J Respir Crit Care Med; 2019 May; 199(9):1097-1105. PubMed ID: 30704260
[No Abstract] [Full Text] [Related]
20. Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock.
Hodge EK; Hughes DW; Attridge RL
Ann Pharmacother; 2016 Oct; 50(10):816-23. PubMed ID: 27340145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
